<?xml version="1.0" encoding="UTF-8"?>
<p>Glutamate is the most important excitatory neurotransmitter in the brain which is involved in different mechanisms of synaptic plasticity, the necessary process for encoding learning and memory phenomena (
 <xref rid="B29" ref-type="bibr">29</xref>). Dysfunction of the ionotropic N-methyl-D-aspartate (NMDA) glutamate receptor is importantly implicated in the neuronal excitotoxicity in AD (
 <xref rid="B30" ref-type="bibr">30</xref>). In late onset AD, Aβ can directly bind to the NMDA receptors, leading to increased extracellular glutamate concentration and excessive activation of the receptor (
 <xref rid="B31" ref-type="bibr">31</xref>). Overactivity of NMDA receptors itself disrupts Ca
 <sup>2+</sup> influx leading to un-regulated intracellular signaling and neurotoxicity; a pathological mechanism recognized in some neurodegenerative disorders, including AD (
 <xref rid="B32" ref-type="bibr">32</xref>). It is also shown that Aβ oligomers have a toxic impact on glucose metabolism via AMP-activated kinase (AMPK). An impaired AMPK destroys synaptic plasticity through NMDA receptors which (
 <xref rid="B33" ref-type="bibr">33</xref>). In an Aβ independent manner, Apo E4 can occupy the NMDA receptors and impair synaptic plasticity in AD (
 <xref rid="B34" ref-type="bibr">34</xref>).
</p>
